Jinlong Wang

Chongqing, 400010, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

STXBP6-driven signaling cascade alters lipid peroxidation in tumor-associated macrophages to facilitate ovarian cancer progression.

STXBP6-driven signaling cascade alters lipid peroxidation in tumor-associated macrophages to facilitate ovarian cancer progression.

Journal: Redox biology
Published: June 26, 2026

Ultraprecise Sign Language Recognition Realized by Self-Recoverable Near-Infrared Mechanoluminescent Materials.

Ultraprecise Sign Language Recognition Realized by Self-Recoverable Near-Infrared Mechanoluminescent Materials.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 03, 2026

Correction: Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.

Correction: Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.

Journal: Oncogene
Published: December 05, 2025

HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of Fibroblasts.

HE4 Might Participate in Extracellular Matrix Remodeling in Ovarian Cancer via Activation of Fibroblasts.

Journal: Oncology research
Published: June 11, 2025

STXBP6 regulates growth, metastasis and lipid metabolism of ovarian cancer cells via the PI3K/AKT signaling pathway.

STXBP6 regulates growth, metastasis and lipid metabolism of ovarian cancer cells via the PI3K/AKT signaling pathway.

Journal: Medical oncology (Northwood, London, England)
Published: May 16, 2025

Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.

Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition.

Journal: Oncogene
Published: February 06, 2025

Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer.

Insights into the role of MSLN-positive circulating tumor cell as an auxiliary diagnostic biomarker in epithelial ovarian cancer.

Journal: Frontiers in oncology
Published: January 19, 2025

The Chinese guideline for management of snakebites.

The Chinese guideline for management of snakebites.

Journal: World journal of emergency medicine
Published: June 06, 2024

Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence.

Prognostic Value of Ki67 in Epithelial Ovarian Cancer: Post-Neoadjuvant Chemotherapy Ki67 Combined with CA125 Predicting Recurrence.

Journal: Cancer management and research
Published: March 15, 2024

Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.

Low PDE4A expression promoted the progression of ovarian cancer by inducing Snail nuclear translocation.

Journal: Experimental cell research
Published: March 12, 2024

Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study.

Lymphadenectomy and optimal excise lymph nodes count for early-stage primary fallopian tube cancer: a SEER-based study.

Journal: BMC women's health
Published: July 31, 2023
Showing 1-11 of 11

Last Updated: 09/26/2026